NOT YOUNG BUT RELEVANT

Welcome to the Brand page for “NOT YOUNG BUT RELEVANT”, which is offered here for Conducting early evaluations in the field of new pharmaceuticals; consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; drug discovery services; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and development; pharmaceutical research services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals for the treatment of age-related diseases and cancer; research in the field of neurodegenerative diseases; research on the subject of pharmaceuticals;.

Its status is currently believed to be active. Its class is unavailable. “NOT YOUNG BUT RELEVANT” is believed to be currently owned by “Lamensdorf, Itschak”.

Owner:
LAMENSDORF, ITSCHAK
Owner Details
Description:
Conducting early evaluations in the field of new pharmaceuticals; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of neurodegenerative diseases; Research on the subject of pharmaceuticals;
Categories: CONDUCTING EARLY EVALUATIONS